Product Pathways - Motif Antibodies
Phospho-(Ser/Thr) Kinase Substrate Antibody Sampler Kit #9920
|Kit Includes||Quantity||Applications||Reactivity||MW (kDa)||Isotype|
|Phospho-(Thr) MAPK/CDK Substrate Mouse mAb #2321||40 µl||W IHC-P E-P||All||Mouse IgM|
|Phospho-Akt Substrate (RXXS*/T*) (110B7E) Rabbit mAb #9614||40 µl||W IP IHC-P E-P||All||Rabbit IgG|
|Phospho-PKA Substrate (RRXS*/T*) (100G7E) Rabbit mAb #9624||40 µl||W IP E-P||All||Rabbit IgG|
|Phospho-(Ser/Thr) ATM/ATR Substrate Antibody #2851||40 µl||W IP IHC-P E-P||All||Rabbit|
|Phospho-(Ser) PKC Substrate Antibody #2261||40 µl||W IP E-P||All||Rabbit|
|Anti-mouse IgG, HRP-linked Antibody #7076||100 µl||Horse|
|Anti-rabbit IgG, HRP-linked Antibody #7074||100 µl||Goat|
|Phospho-(Ser) CDKs Substrate (P-S2-100) Rabbit mAb #9477||40 µl||W IP E-P||All||Rabbit IgG|
Reactivity Key: H=Human M=Mouse R=Rat Mk=Monkey Dm=D. melanogaster Sc=S. cerevisiae All=All Species Expected
Species enclosed in parentheses are predicted to react based on 100% sequence homology.
Specificity / Sensitivity
Each antibody detects endogenous levels of phospho-(Ser/Thr) proteins of specific kinase substrate groups.Phospho-(Ser/Thr) Akt Substrate (110B7E) Rabbit mAb preferentially recognizes peptides and proteins containing phospho-serine/threonine preceded by arginine at positions -5 and -3, in a manner largely independent of the surrounding amino acid sequence. Some cross-reactivity is observed for peptides that contain phospho-serine/threonine preceded by arginine at position -3 . No cross-reactivity is observed with the corresponding nonphosphorylated sequences or with other phospho-serine/threonine-containing motifs. By ELISA, the antibody recognizes a wide range of peptides with phospho-threonine or Phospho-serine with arginine at -3 and -5 position.Phospho-(Ser) PKC Substrate Antibody detects endogenous levels of many cellular proteins only when phosphorylated at serine residues surrounded by Arg or Lys at the -2 and +2 positions and a hydrophobic residue at the +1 position. The antibody does not cross-react with nonphosphorylated serine residues, with phospho-threonine in the same motif, or with phospho-serine in other motifs.Phospho-PKA Substrate (RRXS*/T*) (100G7E) Rabbit mAb detects peptides and proteins containing a phospho-Ser/Thr residue with arginine at the -3 and -2 positions. It is a useful tool in identifying new substrates of PKA. The antibody recognizes other -3 arginine-bearing phospho-Ser/Thr peptides, such as substrate motifs for Akt and PKC, to a lesser extent. It does not recognize the nonphosphorylated substrate motif peptides.Phospho-(Thr) MAPK/CDK Substrate Mouse mAb detects phospho-threonine only when followed by proline. It reacts with proteins/peptides phosphorylated on the Thr-Pro motif in an otherwise highly context-independent fashion. The antibody does not cross-react with phospho-threonine in the absence of an adjacent proline. The antibody does not cross-react with phospho-tyrosine, but does react with some phospho-serine peptides containing the phospho-serine-proline motif (e.g., phospho-Elk-1).Phospho-(Ser) CDKs Substrate (P-S2-100) Rabbit mAb recognizes phospho-serine in a KS*P motif. The antibody does not cross-react with phospho-threonine or phospho-tyrosine containing peptides/proteins.Phospho-(Ser/Thr) ATM/ATR Substrate Antibody detects endogenous levels of proteins containing the ATM/ATR substrate motif. This antibody preferentially binds peptides and proteins that contain phospho-Ser/Thr preceded by Leu or similar hydrophobic amino acids at the -1 position and followed by Gln at the +1 position. The antibody does not cross-react with corresponding nonphosphorylated sequences or with other phospho-Ser/Thr-containing motifs.
Western blot analysis of whole cell lysates of Jurkat cells untreated and treated with PMA (50 ng/ml) and ionomycin (1 µM) for 20 minutes prior to lysis. Proteins were separated by 2D electrophoresis prior to blotting and probed with Phospho-(Ser) PKC Substrate Antibody #2261.
Western blot analysis of whole cell lysates from Jurkat cells untreated and treated with 1 µg/ml nocodazole for 12 hours prior to lysis, using Phospho-(Thr) MAPK/CDK Substrate mAb #2321. Proteins were separated by 2D electrophoresis prior to blotting.
Western blot analysis of extracts from HeLa cells either untreated or treated with the microtubule destabilizing agents nocodazole or paclitaxol, using Phospho-(Ser) CDKs Substrate Antibody #2324.
Chk2 transfected and UV treated COS cell extracts immunoprecipitated with Chk2 antibody then detected by Western blotting using Phospho-(Ser/Thr) ATM/ATR Substrate Antibody #2851.
Western blot analysis of extracts from COS-7 cells, synchronized in G1/S, G2/M, and G0 phase of the cell cycle, using Phospho-(Ser) CDKs Substrate (P-S2-100) Rabbit mAb.
Western blot analysis of extracts from serum-starved NIH/3T3 cells, phosphorylated in vitro with Akt kinase, or treated in culture with PDGF or FBS/Calyculin A, using Phospho-(Ser/Thr) Substrate (110B7E) Rabbit mAb #9614.
Western blot analysis of extracts from serum-starved A431 cells, phosphorylated in vitro with PKA kinase or treated in culture with forskolin/IBMX, using Phospho-PKA Substrate (RRXS*/T*) (100G7E) Rabbit mAb #9624. Lysis buffer: 1.0% Triton X-100 (lanes 1 and 2), 2.0% SDS (lanes 3 and 4).
Phospho-(Ser) PKC Substrate Antibody #2261 ELISA assay: Signal-to-noise ratio of phospho- versus nonphospho-peptides. (S* denotes phosphorylated serine.)
Signal to noise ratio of ELISA reading, using Phospho-(Thr) MAPK/CDK Substrate mAb #2321 with phospho-Thr-Pro containing peptides (T*P) and nonphospho-Thr-Pro containing peptides. (T* denotes phosphorylated threonine.)
Phospho-(Ser/Thr) ATM/ATR Substrate Antibody #2851 ELISA assay: Signal-to-noise ratio of phospho- versus nonphospho-peptides. (S* or T* denote phosphorylated serine or threonine.)
Phospho-(Ser/Thr) Akt Substrate (110B7E) mAb #9614 ELISA assay: Signal-to-noise ratio of phospho- versus nonphospho-peptides. (T* and S* denote phosphorylated threonine and serine.)
Phospho-PKA Substrate (RRXS*/T*) (100G7E) Rabbit mAb #9624: Signal-to-noise ratio of phospho- versus nonphospho-peptides. (T* and S* denote phosphorylated threonine and serine.)
Phospho-(Ser/Thr) Kinase Substrate Antibody Sampler Kit contains 40 µl of each polyclonal primary antibody [Phospho-(Ser) PKC Substrate Antibody and Phospho-(Ser/Thr) ATM/ATR Substrate Antibody], 40 µl each of Phospho-(Ser) CDKs Substrate (P-S2-100) Rabbit mAb, Phospho-(Ser/Thr) Akt Monoclonal Substrate Antibody, Phospho-(Ser/Thr) PKA Substrate Antibody, and 40 µl of Phospho-(Thr) MAPK/CDK Substrate mAb.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with phosphopeptides containing the kinase substrate motif and purified by protein A and peptide affinity chromatography.Monoclonal antibody is produced by immunizing animals with synthetic phosphopeptides .Mouse monoclonal antibody (isotype: IgM) is produced by immunizing mice with a phospho-(Thr) MAPK/CDK substrate motif-containing peptide and is purified by protein A chromatography.
Phospho-(Ser/Thr) kinases and phosphatases play critical roles in a wide range of biological processes. Each phospho-(Ser/Thr) kinase phosphorylates serine or threonine within a specific motif. Akt phosphorylates substrates at a serine or threonine only in a conserved motif characterized by arginine at positions -5 and -3 (1). Conventional PKC isozymes phosphorylate substrates containing serine or threonine, with arginine or lysine at the -3, -2 and +2 positions, and a hydrophobic amino acid at position +1 (2,3). A consensus phosphorylation site of PKA is serine or threonine with arginine at the -2 and -3 positions (3). The MAPK and CDK families of serine/threonine protein kinases phosphorylate threonine or serine followed by proline residue (3-5).The consensus amino acid sequence for CDK substrate is (K/R)(S*)PX(K/R), where denotes any one of the 20 amino acids and S* is the phosphorylation site (6-8). ATM and the related kinase ATR phosphorylate serine or threonine in an S*/T*Q motif (9,10).Antibodies specific to particular kinase substrates are invaluable reagents in determining kinase activity and identifying potential new kinase substrates. CST has developed antibodies that recognize phosphorylated serine or threonine within the context of a protein motif that is phosphorylated by Akt, PKC, PKA, MAPK/CDK, CDKs or ATM/ATR. As shown by peptide pairing ELISA, each phospho-(Ser/Thr) kinase substrate antibody in this sampler kit is specific to its kinase substrate motif.
- Alessi, D.R. et al. (1996) FEBS Lett 399, 333-8.
- Nishikawa, K. et al. (1997) J. Biol. Chem. 272, 952-960.
- Pearson, R.B. and Kemp, B.E. (1991) Methods Enzymol. 200, 62-81.
- Karin, M. (1994) Curr. Opin. Cell Biol. 6, 415-424.
- Lewis, T.S. et al. (1998) Adv. Cancer Res. 74, 49-139.
- Songyang, Z. et al. (1996) Mol. Cell Biol. 16, 6486-6493.
- Songyang, Z. (1999) Prog. Biophys. Mol. Biol. 71, 359-372.
- Holmes, J.K. and Solomon, M.J. (1996) J. Biol. Chem. 271, 25240-25246.
- Kastan, M.B. and Lim, D.S. (2000) Nat. Rev. Mol. Cell Biol. 1, 179-186.
- Zhao, H. and Piwnica-Worms, H. (2001) Mol. Cell Biol. 21, 4129-4139.
- Xu, W. et al. (2003) Cancer Res 63, 7777-84. Applications: Western Blotting
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 2909 Phospho-(Ser/Thr) ATM/ATR Substrate (4F7) Rabbit mAb
- 2351 Phospho-Threonine-X-Arginine Antibody
- 2981 Phospho-(Ser) Arg-X-Tyr/Phe-X-pSer Motif Antibody
- 9601 Phospho-(Ser) 14-3-3 Binding Motif Antibody
- 9606 Phospho-(Ser) 14-3-3 Binding Motif (4E2) Mouse mAb
- 9631 Phospho-(Ser/Thr) Phe Antibody
- 9634 Phospho-(Ser/Thr) PDK1 Docking Motif (18A2) Mouse mAb
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7076 Anti-mouse IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
License/Use Restrictions: Use of CST Motif Antibodies within certain methods (e.g., U.S. Patent No.'s 7,198,896 & 7,300,753) may require a license from CST. For information regarding academic licensing terms please have your technology transfer office contact CST Legal Department at CST_ip@cellsignal.com. For information regarding commercial licensing terms please contact CST Pharma Services Department at email@example.com.
For Research Use Only. Not For Use In Diagnostic Procedures.